Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
VRTX
Financials
Long-term debt
VRTX
Vertex Pharmaceuticals Incorporated
Backtest
VRTX
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Cash flow
Balance sheet
Cash
Long-term debt
Equity
Total assets
Total liabilities
Valuation
Shares and dividends
Costs
Long-term debt
Long-term debt, 2025
$0
Annual
Quarterly
Long-term debt
Annual
Quarterly
Value
YoY
5Y
10Y
Max
Value
YoY
5Y
10Y
Max
Long-term debt by fiscal year
CSV
Period
On
Long-term debt
YoY
Filing
2025
2025
Dec 31, 2025
$0
—
10-Q, Nov 3, 2026
More Vertex Pharmaceuticals financials
Cash
Equity
Total assets
Total liabilities
Revenue
Gross profit
Long-term debt at other companies
CVS
CVS Health Corporation
MCK
McKesson Corporation
BSX
Boston Scientific Corporation
ILMN
Illumina, Inc.
NTRA
Natera, Inc.
ELV
Elevance Health, Inc.
Tools
Return calculator